€76.95 -4.7 -5.7%
Last Trade - 4:35pm
| Market Cap | £1.45bn |
| Enterprise Value | £1.39bn |
| Revenue | £152.1m |
| Position in Universe | 335th / 1049 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 139.7 | 137.9 | 138.6 | 168.7 | 178.5 | 176.1 | 184 | 215.6 | +4.7% | ||
| -35.6 | +106.8 | +9.5 | +56.0 | +49.8 | -5.6 | +39.9 | +24.2 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | December 10, 1997 |
| Public Since | February 25, 2008 |
| No. of Shareholders: | n/a |
| No. of Employees: | 828 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | Xetra Prime All Share , |
| Exchange | XETRA |
| Shares in Issue | 20,589,976 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Robert-Roessle-Str10, BERLIN, 13125, Germany |
| Web | https://www.ezag.com/ |
| Phone | +49 30 9410840 |
| Contact | Karolin Riehle (Investor Relations) |
| Auditors | BDO AG Wirtschaftsprufungsgesellschaft |
As of 4:35pm, shares in Eckert & Ziegler Strahlen und Medizintechnik AG are trading at €76.95, giving the company a market capitalisation of £1.45bn. This share price information is delayed by 15 minutes.
Shares in Eckert & Ziegler Strahlen und Medizintechnik AG are currently trading at €76.95 and the price has moved by 0.137k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Eckert & Ziegler Strahlen und Medizintechnik AG price has moved by 85.38% over the past year.
Of the analysts with advisory recommendations for Eckert & Ziegler Strahlen und Medizintechnik AG, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Eckert & Ziegler Strahlen und Medizintechnik AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Eckert & Ziegler Strahlen und Medizintechnik AG is scheduled to issue upcoming financial results on the following dates:
The Eckert & Ziegler Strahlen und Medizintechnik AG dividend yield is 0.55% based on the trailing twelve month period.
Last year, Eckert & Ziegler Strahlen und Medizintechnik AG paid a total dividend of 0.45, and it currently has a trailing dividend yield of 0.55%. Looking ahead, shares in Eckert & Ziegler Strahlen und Medizintechnik AG are due to go ex-dividend on 2021-06-03 and the next dividend pay date is 2021-06-07.
Eckert & Ziegler Strahlen und Medizintechnik AG are due to go ex-dividend on 2021-06-03 and the next dividend pay date is 2021-06-07. The historic dividend yield on Eckert & Ziegler Strahlen und Medizintechnik AG shares is currently 0.55%.
To buy shares in Eckert & Ziegler Strahlen und Medizintechnik AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Eckert & Ziegler Strahlen und Medizintechnik AG are currently trading at €76.95, giving the company a market capitalisation of £1.45bn.
Here are the trading details for Eckert & Ziegler Strahlen und Medizintechnik AG:
Based on an overall assessment of its quality, value and momentum, Eckert & Ziegler Strahlen und Medizintechnik AG is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Eckert & Ziegler Strahlen und Medizintechnik AG are currently priced at €76.95. At that level they are trading at 8.64% premium to the analyst consensus target price of 0.00.
Analysts covering Eckert & Ziegler Strahlen und Medizintechnik AG currently have a consensus Earnings Per Share (EPS) forecast of 1.32 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eckert & Ziegler Strahlen und Medizintechnik AG. Over the past six months, the relative strength of its shares against the market has been 75.74%. At the current price of €76.95, shares in Eckert & Ziegler Strahlen und Medizintechnik AG are trading at 60.15% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Eckert & Ziegler Strahlen und Medizintechnik AG PE ratio based on its reported earnings over the past 12 months is 86.51. The shares are currently trading at €76.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Eckert & Ziegler Strahlen und Medizintechnik AG's management team is headed by:
Here are the top five shareholders of Eckert & Ziegler Strahlen und Medizintechnik AG based on the size of their shareholding:
